Abstract

BackgroundIn Japan in 2014 the market share for generic drugs was 50%, lower than that of Western nations, but the reasons why the patients themselves turn down the opportunity to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call